Teva
Global medicines company with a broad generics portfolio and innovative branded medicines concentrated in neuroscience and immunology.
Therapeutic areas
Selected products and programs
Linked curated drug profiles
Selected active clinical trials
Phase 3 · Recruiting · Asthma
A Trial to Assess TEV-56286 at Different Doses in Healthy ParticipantsPhase 1 · Recruiting · Healthy Volunteers
A Trial to Test if TEV-56286 is Effective for Treatment of Participants With Multiple System AtrophyPhase 2 · Recruiting · Multiple System Atrophy
An Extension Trial to Test if TEV-56286 is Effective in Relieving Multiple System AtrophyPhase 2 · Recruiting · Multiple System Atrophy
An Open-label Dose Escalation/Expansion Trial to Evaluate the Safety and Anti-tumor Activity of TEV-56278 Alone or in Combination With Pembrolizumab in Participants With Advanced or Metastatic Solid TumorsPhase 1 · Recruiting · Advanced Solid Tumors
A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma ExacerbationsPhase 3 · Active Not Recruiting · Asthma
Selected patent records
Primary and company sources
Company and pipeline information can change. Verify material decisions against the linked primary sources.
Evidence & limits
Source: Open the source record
- Record identifier
- /companies/teva/
- Event / action date
- Not separately retained
- Source update date
- Not separately retained
- Platform retrieval / processing date
- Not separately retained
What it supports. Connections found through the catalog, identifiers, or name and alias matching, with source links where retained.
Limits. A company association is not proof of ownership or sponsorship of every linked record. Product, substance, parent-company, and subsidiary relationships may differ.
Connection basis. Catalog, identifier, or normalized name association. Product and company connections are research leads, not ownership determinations.